Douglas Smith, MD
Rheumatology · Indianapolis, INNPI 1407832025
Payments from drug & device makers
Across 456 payments — averaging $322.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$42K
- United Rheumatology$29K
- Lilly USA, LLC$29K
- Johnson & Johnson$14K
- E.r. Squibb & Sons, L.L.C.$9K
- Janssen Scientific Affairs, LLC$5K
- plus $18K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 71 | $42,276 |
| United Rheumatology | 5 | $28,900 |
| Lilly USA, LLC | 50 | $28,589 |
| Johnson & Johnson | 36 | $14,478 |
| E.r. Squibb & Sons, L.L.C. | 30 | $8,949 |
| Janssen Scientific Affairs, LLC | 10 | $5,273 |
| Mallinckrodt Enterprises LLC | 20 | $5,257 |
| AbbVie | 43 | $5,008 |
| Amgen(2 entities) | 74 | $4,045 |
| GSK | 13 | $615 |
| UCB, Inc. | 13 | $595 |
| Mallinckrodt Hospital Products Inc. | 8 | $526 |
| AstraZeneca(2 entities) | 10 | $427 |
| Boehringer Ingelheim | 6 | $375 |
| Aurinia Pharma U.S., Inc. | 4 | $297 |
| Pfizer | 16 | $289 |
| Radius Health, Inc. | 7 | $169 |
| Sobi, Inc | 2 | $165 |
| Regeneron Healthcare Solutions, Inc. | 6 | $123 |
| Bristol Myers Squibb | 5 | $76 |
| Genentech USA, Inc. | 3 | $64 |
| Merck | 3 | $45 |
| Pacira Therapeutics, Inc. | 2 | $44 |
| Organon | 2 | $42 |
| Ferring Pharmaceuticals Inc. | 2 | $34 |
| Gilead | 2 | $32 |
| Kyowa Kirin, Inc. | 1 | $29 |
| Antares Pharma, Inc. | 2 | $27 |
| Orthogenrx Inc. | 2 | $27 |
| Octapharma USA, Inc. | 1 | $25 |
| Fidia Pharma USA Inc. | 2 | $22 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $13 |
| Medexus Pharma, Inc. | 1 | $11 |
How this compares
$146,896 in reported general payments places this provider in the 95th percentile of 106 rheumatology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Indianapolis
- David BattIndianapolis$577K
- Inna AroutiounovaIndianapolis$102K
- James CohenIndianapolis$76K
- Steven HugenbergIndianapolis$50K
- James EhlichIndianapolis$27K
- Christopher WuIndianapolis$26K
- Michael StackIndianapolis$21K
- Methee SrivatanaIndianapolis$10K
- Mary JacobsIndianapolis$9K
- Randall ReedIndianapolis$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.